Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Theseus Pharmaceuticals Inc (THRX)

Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theseus Pharmaceuticals Inc 314 MAIN STREET CAMBRIDGE MA 02142 USA

www.theseusrx.com P: 857-400-9491

Description:

Theseus Pharmaceuticals Inc. is a biopharmaceutical company. It focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's principal product candidate includes THE-630. Theseus Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 179,574
Enterprise Value, $K 84,964
Shares Outstanding, K 44,230
Annual Sales, $ 0 K
Annual Net Income, $ -50,610 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,500 K
EBIT, $ -66,530 K
EBITDA, $ -67,140 K
60-Month Beta 3.98
% of Insider Shareholders 46.70%
% of Institutional Shareholders 91.05%
Float, K 23,575
% Float 53.30%
Short Volume Ratio 0.28

Growth:

1-Year Return -63.91%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 11/17/23
Next Earnings Date 03/14/24
Earnings Per Share ttm -1.34
EPS Growth vs. Prev Qtr 8.82%
EPS Growth vs. Prev Year 18.42%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 09/08/15
Dividend Payable Date 12/23/14
Dividend Payout Ratio 0.00%

THRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.84%
Return-on-Assets % -23.64%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.79
Book Value/Share 5.15
Interest Coverage -1.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar